AU Patent

AU2018369241B2 — Pharmaceutical preparation having excellent photostability and drug release properties

Assigned to Shionogi and Co Ltd · Expires 2023-01-05 · 3y expired

What this patent protects

The present invention provides a preparation which remains substantially uncolored even when irradiated with light, by coating a preparation containing the compound represented by formula (I), a salt of said compound, or a crystal of these compounds with a photostable substance a…

USPTO Abstract

The present invention provides a preparation which remains substantially uncolored even when irradiated with light, by coating a preparation containing the compound represented by formula (I), a salt of said compound, or a crystal of these compounds with a photostable substance and a polymer molecule, using, in particular, at least one substance from among titanium oxide and talc as the photostable substance and hypromellose as the polymer molecule.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018369241B2
Jurisdiction
AU
Classification
—
Expires
2023-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Shionogi and Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.